Literature DB >> 10052911

Incorporation rates, stabilities, cytotoxicities and release of liposomal tetracycline and doxycycline in human serum.

L Sangaré1, R Morisset, A Omri, M Ravaoarinoro.   

Abstract

Tetracycline and doxycycline were encapsulated in cationic, anionic and neutral liposomes. The amounts of antibiotic encapsulated, the stability of each preparation at 4 degrees C for 4 weeks, and the kinetics of the release of entrapped drug into human sera were assessed by high-performance liquid chromatography. The toxicities of the liposome preparations on human erythrocytes and HeLa 229 cells were evaluated in vitro. The results showed that doxycycline was entrapped more efficiently than tetracycline, and that doxycycline-entrapped liposomes were more stable at 4 degrees C and in human sera, and less cytotoxic than tetracycline-entrapped liposomes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10052911     DOI: 10.1093/jac/42.6.831

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  A Novel Loading Method for Doxycycline Liposomes for Intracellular Drug Delivery: Characterization of In Vitro and In Vivo Release Kinetics and Efficacy in a J774A.1 Cell Line Model of Mycobacterium smegmatis Infection.

Authors:  Rebekah K Franklin; Sarah A Marcus; Adel M Talaat; Butch K KuKanich; Ruth Sullivan; Lisa A Krugner-Higby; Timothy D Heath
Journal:  Drug Metab Dispos       Date:  2015-06-01       Impact factor: 3.922

2.  Inhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cells.

Authors:  Joyce A Ibana; Robert J Belland; Arnold H Zea; Danny J Schust; Takeshi Nagamatsu; Yasser M AbdelRahman; David J Tate; Wandy L Beatty; Ashok A Aiyar; Alison J Quayle
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

3.  Nanoliposomal minocycline for ocular drug delivery.

Authors:  James M Kaiser; Hisanori Imai; Jeremy K Haakenson; Robert M Brucklacher; Todd E Fox; Sriram S Shanmugavelandy; Kellee A Unrath; Michelle M Pedersen; Pingqi Dai; Willard M Freeman; Sarah K Bronson; Thomas W Gardner; Mark Kester
Journal:  Nanomedicine       Date:  2012-03-28       Impact factor: 5.307

4.  Reactivating hippocampal-mediated memories during reconsolidation to disrupt fear.

Authors:  Stephanie L Grella; Amanda H Fortin; Evan Ruesch; John H Bladon; Leanna F Reynolds; Abby Gross; Monika Shpokayte; Christine Cincotta; Yosif Zaki; Steve Ramirez
Journal:  Nat Commun       Date:  2022-09-12       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.